Aborted myocardial infarction: A new target for reperfusion therapy

European Heart Journal

Volumn 27, Issue 8, 2006, Pages 901-904

  Verheugt, Freek W A ^a   Gersh, Bernard J ^b   Armstrong, Paul W ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Abortion; Creatine kinase; Myocardial infarction; Reperfusion therapy

Indexed keywords

CREATINE KINASE MB; FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; CORONARY ARTERY DISEASE; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DRUG TARGETING; ELECTROCARDIOGRAM; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ST SEGMENT ELEVATION; STROKE; SURVIVAL RATE; TISSUE NECROSIS; TREATMENT OUTCOME; VASOCONSTRICTION;

EMERGENCY TREATMENT; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; TIME FACTORS;

EID: 33645467821     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi829     Document Type: Review

References (22)

1. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic therapy in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-775.
2. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size versus duration of coronary occlusion in dogs. Circulation 1977;56:786-794.
3. Bergmann SR, Lerch RA, Fox KAA, Ludbrook PA, Welch MJ, Ter-Pogossian MM, Sobel BE. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron emission tomography. Am J Med 1982;73:573-580.
4. Gersh BJ, Stone GW, White HD, Holmes DR. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 2005;293:979-986.
5. Huber K, De Caterina R, Kristensen SD, Verheugt FWA, Montalescot G, Badimon L, Van de Werf F. Prehospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J 2005;26:2063-2074.
6. Koren G, Weiss AT, Hasin Y, Appelbaum D, Weiber S, Rozenman Y, Lotan C, Mosseri M, Sapoznikov D, Luria MH, Gotsman MS. Prevention of myocardial damage in acute myocardial infarction by early treatment with intravenous streptokinase. N Engl J Med 1985;313:1384-1389.
7. Rawles J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial. J Am Coll Cardiol 1994;23:1-5.
8. Trent R, Adams J, Rawles J. Electrocardiographic evidence of reperfusion occurring before hospital admission. Eur Heart J 1994;15:895-897.
9. Antman EM, Cooper HA, Gibson CM, De Lemos JA, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Van de Werf F, Braunwald E. Determinants of improvement of epicardial flow and myocardial perfusion for ST-elevation myocardial infarction. Eur Heart J 2002;23:928-933.
10. Fu Y, Goodman S, Wei-Ching C, Van de Werf F, Granger CB, Armstrong PW. Time to treatment influences the impact of ST-segment resolution on one-year prognosis. Circulation 2001;104:2653-2659.
11. Weaver WD, Cerquiera M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarct Triage and Intervention Trial. JAMA 1993;270:1211-1216.
12. Davies GJ, Chierchia S, Maseri A. Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. N Engl J Med 1984;331:1488-1492.
13. Taher T, Fu Y, Wagner GS, Goodman SG, Fresco C, Granger GB, Wallentin L, Verheugt F, Van de Werf F, Armstrong PW. Aborted myocardial infarction in patients with ST-segment elevation: insights from the ASSENT-3 ECG substudy. J Am Coll Cardiol 2004;44:38-43.
14. Lamfers EJP, Hooghoudt TEH, Uppelschoten A, Stolwijk EPJ, Verheugt FWA. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol 1999;84:928-930.
15. Clappers N, Dieker HJ, Brouwer MA, Van den Bergh PJ, Aengevaeren WR, Veen G, Verheugt FWA. Aborted myocardial infarction: absence of enzyme rise after fibrinolysis as a predictor of future infarction and a warrant for early intervention. (Abstract). Circulation 2004;110(Suppl. III):540.
16. Lamfers EJP, Hooghoudt TEH, Hertzberger DP, Schut A, Stolwijk PWJ, Verheugt FWA. Abortion of ST-segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. Heart 2003;89:496-501.
17. Schömig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, Martinoff S, Neumann FJ, Schwaiger M. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343:385-391.
18. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schömig A. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis in acute myocardial infarction: a randomised trial. Lancet 2002;359:920-925.
19. Kastrati A, Mehilli J, Nekolla S, Bollwein H, Martinoff S, Pache J, Schuhlen H, Seyfarth M, Gawaz M, Neumann FJ, Diorschinger J, Schwaiger M, Schömig A. A randomised trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 2004;43:734-741.
20. Lamfers EJP, Hooghoudt TEH, Uppelschoten A, Stolwijk PWJ, Boersma E, Simoons ML, Verheugt FWA. Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist ECG diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy. Am Heart J 2004;147: 509-515.
21. Wilcox RG, Von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR (for the ASSET study group). Effects of alteplase in acute myocardial infarction: 6 months results from the ASSET study. Lancet 1990;335:1175-1178.
22. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. European Society of Cardiology guidelines for percutaneous coronary interventions. Eur Heart J 2005;26:804-847.